Streetbeat News

Earnings

SGRY

Surgery Partners reported better-than-expected Q3 results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 4:56 pm

MSFT

Microsoft Corporation (NASDAQ:MSFT) shares are trading higher, with a gain of nearly 7% over the last five days and more than 13% over the last month. This follows several game updates and releases by Blizzard Entertainment, a division of Activision Blizzard, which was recently acquired by Microsoft. Microsoft's Q1 financial reports also exceeded expectations, with earnings of $2.99 per share and quarterly revenue of $56.517 billion.

Portfolio Pulse from Erica Kollmann

November 07, 2023 | 4:42 pm

CRWD

DDOG

Shares of CrowdStrike Holdings, Inc. (NASDAQ:CRWD) are trading higher in sympathy with Datadog Inc. (NASDAQ:DDOG), after Datadog reported better-than-expected Q3 financial results and issued strong guidance. Datadog's shares are up more than 29% at $102.74, while CrowdStrike's shares are up nearly 4% at $194.15.

Portfolio Pulse from Erica Kollmann

November 07, 2023 | 4:36 pm

GILT

Gilat Satellite Networks Ltd reported Q3 FY23 revenue growth of 6% YoY to $63.9 million, missing the consensus of $67.9 million. Adjusted operating income was $6.1 million, up from $2.4 million a year ago. The company tightened its FY23 revenue forecast to $265 million-$275 million and raised operating income guidance to $29 million-$31 million. GILT shares were down 8.1% following the announcement.

Portfolio Pulse from Anusuya Lahiri

November 07, 2023 | 4:32 pm

TMDX

TransMedics Group Inc reported Q3 revenues of $66.4 million, a 159% Y/Y increase, beating the consensus of $49.19 million. The increase was due to greater utilization of the company's NOP across all three OCS products and the addition of logistics and aviation revenue. The company reported a Q3 EPS loss of $(0.78), down from $(0.25) a year ago. TransMedics has updated its FY23 revenues guidance to $222 million-$230 million, compared to prior guidance of $180 million-$190 million.

Portfolio Pulse from Vandana Singh

November 07, 2023 | 4:30 pm

GMAB

Genmab A/S has updated its 2023 operating profit guidance to be in the range of DKK 4,800M – DKK 5,750M, compared to the previous guidance of DKK 4,500M – DKK 6,000M. The updated guidance is driven by higher total royalty revenues from Darzalex and other products.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 4:29 pm

GMAB

Genmab A/S has revised its 2023 operating expenses guidance to be in the range of DKK 10,600M – DKK 10,900M, up from the previous guidance of DKK 10,400M – DKK 10,900M.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 4:28 pm

GMAB

Genmab has updated its 2023 financial guidance, expecting its revenue to be in the range of DKK 15,900M - DKK 16,500M, an increase from the previous guidance of DKK 15,500M – DKK 16,500M. The company's Q3 net profit was DKK 2,129M, down from DKK 2,582M YoY.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 4:28 pm

GH

Guardant Health Inc (NASDAQ:GH) reported Q3 revenue of $143 million, up 22% Y/Y, beating the consensus of $137.37 million. The company also posted a smaller than expected Q3 loss and raised its annual sales outlook. However, GH shares are down 5.70% at $26.16 on the last check Tuesday.

Portfolio Pulse from Vandana Singh

November 07, 2023 | 4:26 pm

ELAN

Elanco Animal Health reported strong Q3 results and raised its FY23 guidance, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 4:23 pm